Path Traversal in AWS Aws-Healthomics-Mcp-Server

CVE-2026-15415

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 5.5 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N.

EPSS exploit prediction

EPSS: 0.004 (27.3th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 27th percentile — 27.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2026-15415: held from 0.004 to 0.004.

EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2026-15415?
CVE-2026-15415 is a medium-severity vulnerability in AWS Aws-Healthomics-Mcp-Server, classified under Relative Path Traversal. CVSS score: 5.5/10. Published 2026-07-17.
How severe is CVE-2026-15415?
Medium severity. CVSS v3 base score is 5.5 out of 10.